• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

成人烟雾病缺血型患者行颅内外血管搭桥术后的长期转归。

Long-term Outcomes After Encephaloduroarteriosynangiosis in Adult Patients with Moyamoya Disease Presenting with Ischemia.

机构信息

Department of Neurosurgery, 307th Hospital of People's Liberation Army, Center for Cerebral Vascular Disease, Beijing, China.

Department of Neurosurgery, 307th Hospital of People's Liberation Army, Center for Cerebral Vascular Disease, Beijing, China; Department of Neurosurgery, 307th Hospital of People's Liberation Army, 307 Clinical College, Anhui Medical University, Beijing, China.

出版信息

World Neurosurg. 2018 Jul;115:e482-e489. doi: 10.1016/j.wneu.2018.04.076. Epub 2018 Apr 21.

DOI:10.1016/j.wneu.2018.04.076
PMID:29684518
Abstract

BACKGROUND

In adult Moyamoya disease (MMD), there remains controversy about the effectiveness of revascularization surgeries because randomized studies have not been performed to compare the efficacy of surgical techniques. This study was conducted to assess the most appropriate surgical treatment for adult patients with MMD.

METHODS

Encephaloduroarteriosynangiosis (EDAS) was performed on 247 hemispheres in 145 patients. The clinical and demographic characteristics of patients were obtained via retrospective chart review. Clinical and angiographic states were evaluated retrospectively using quantitative methods. The mean duration of clinical follow up was 141.4 ± 19.5 months.

RESULTS

A total of 247 EDAS procedures were performed in 145 patients, including 15 EDAS performed using the occipital artery as the donor vessel. The mortality rate was 0%, and the permanent morbidity rates were 1.2% per operation and 2.0% per person. The mean modified Rankin Scale score was 1.21 ± 1.31 postoperatively and 1.01 ± 1.39 at the last follow-up. Of the 109 hemispheres studied, 45% were classified as grade A, 34% as grade B, and 21% as grade C collateral circulation. The annual rates of stroke were calculated to be 0.73% per person-year. Overall, the 1-,5-, and 10-year actuarial stroke rates were 2.1±1.2%, 6.8±2.1%, and 8.9±2.4%, respectively. Bilateral involvement was a common significant factor in any, hemorrhagic, and ischemic strokes. Hypertension was a risk factor for ischemic strokes during follow-up.

CONCLUSIONS

EDAS is an effective procedure in a Chinese cohort of patients with MMD. EDAS resulted in satisfactory long-term improvement of clinical states and prevention of recurrent strokes.

摘要

背景

成人烟雾病(MMD)中,由于尚未开展比较手术技术疗效的随机研究,因此对于血运重建手术的有效性仍存在争议。本研究旨在评估最适合成人 MMD 患者的外科治疗方法。

方法

对 145 例患者的 247 个半脑进行了颅内外血管搭桥术(EDAS)。通过回顾性病历审查获得患者的临床和人口统计学特征。使用定量方法回顾性评估临床和血管造影状态。平均临床随访时间为 141.4±19.5 个月。

结果

在 145 例患者中进行了 247 次 EDAS 手术,其中 15 次手术采用枕动脉作为供体血管。死亡率为 0%,手术永久性并发症发生率为 1.2%/次,患者永久性并发症发生率为 2.0%/人。术后平均改良 Rankin 量表评分为 1.21±1.31,末次随访时为 1.01±1.39。在研究的 109 个半脑中,45%被分类为 A 级,34%为 B 级,21%为 C 级侧支循环。计算得出每年的卒中发生率为 0.73%/人年。总的来说,1、5 和 10 年的累积卒中发生率分别为 2.1±1.2%、6.8±2.1%和 8.9±2.4%。双侧受累是任何、出血性和缺血性卒中的共同重要因素。高血压是随访期间缺血性卒中的危险因素。

结论

EDAS 是中国 MMD 患者的一种有效治疗方法。EDAS 可长期显著改善临床状态并预防复发性卒中。

相似文献

1
Long-term Outcomes After Encephaloduroarteriosynangiosis in Adult Patients with Moyamoya Disease Presenting with Ischemia.成人烟雾病缺血型患者行颅内外血管搭桥术后的长期转归。
World Neurosurg. 2018 Jul;115:e482-e489. doi: 10.1016/j.wneu.2018.04.076. Epub 2018 Apr 21.
2
Outcome of repeat revascularization surgery for moyamoya disease after an unsuccessful indirect revascularization. Clinical article.烟雾病间接血运重建术后再复发行血运重建术的结果。临床文章。
J Neurosurg. 2011 Aug;115(2):328-36. doi: 10.3171/2011.3.JNS101908. Epub 2011 Apr 29.
3
Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya.北美烟雾病成年患者脑-硬脑膜-动脉血管融通术后的手术结果
J Neurosurg. 2014 Dec;121(6):1394-400. doi: 10.3171/2014.8.JNS132176. Epub 2014 Oct 3.
4
Encephaloduroarteriosynangiosis for hemorrhagic moyamoya disease: long-term outcome of a consecutive series of 95 adult patients from a single center.硬脑膜动脉血管融通术治疗出血性烟雾病:单中心连续 95 例成人患者的长期结果。
J Neurosurg. 2019 Jun;130(6):1898-1905. doi: 10.3171/2017.12.JNS172246. Epub 2018 Jun 1.
5
Encephaloduroarteriosynangiosis for pediatric moyamoya disease: long-term follow-up of 100 cases at a single center.小儿烟雾病的脑-硬脑膜-动脉血管融合术:单中心100例长期随访
J Neurosurg Pediatr. 2018 Aug;22(2):173-180. doi: 10.3171/2018.2.PEDS17591. Epub 2018 Jun 1.
6
Clinical features, surgical treatment and long-term outcome in adult patients with Moyamoya disease in China.中国成人烟雾病的临床特征、外科治疗和长期预后。
Cerebrovasc Dis. 2012;34(4):305-13. doi: 10.1159/000343225. Epub 2012 Nov 8.
7
Stroke prevention by direct revascularization for patients with adult-onset moyamoya disease presenting with ischemia.通过直接血运重建对成年起病的烟雾病伴缺血患者进行卒中预防。
J Neurosurg. 2016 Jun;124(6):1788-93. doi: 10.3171/2015.6.JNS151105. Epub 2015 Dec 4.
8
Clinical features and long-term outcomes of moyamoya disease: a single-center experience with 528 cases in China.烟雾病的临床特征与长期预后:中国单中心528例病例经验
J Neurosurg. 2015 Feb;122(2):392-9. doi: 10.3171/2014.10.JNS132369. Epub 2014 Nov 28.
9
Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.脑硬脑膜动脉血管吻合术和脑肌动脉血管吻合术用于治疗镰状细胞病小儿患者的烟雾病综合征
J Neurosurg Pediatr. 2015 Jul;16(1):64-73. doi: 10.3171/2014.12.PEDS14522. Epub 2015 Apr 3.
10
Surgical outcomes following encephaloduroarteriosynangiosis in adult moyamoya disease associated with Type 2 diabetes.成人合并 2 型糖尿病的烟雾病行颅内外血管搭桥术后的手术效果。
J Neurosurg. 2016 Aug;125(2):308-14. doi: 10.3171/2015.7.JNS15218. Epub 2016 Jan 8.

引用本文的文献

1
Outcomes of bypass surgery in asymptomatic moyamoya angiopathy: A multicenter study with propensity-score weighting.无症状烟雾病血管病搭桥手术的疗效:一项倾向评分加权的多中心研究
Eur Stroke J. 2025 Aug 30:23969873251365504. doi: 10.1177/23969873251365504.
2
Treatment for moyamoya disease with hyperhomocysteinemia.伴有高同型半胱氨酸血症的烟雾病的治疗。
J Cereb Blood Flow Metab. 2025 Mar 13:271678X251325676. doi: 10.1177/0271678X251325676.
3
Isolated anterior cerebral artery occlusion: an atypical form of moyamoya disease.孤立性大脑前动脉闭塞:烟雾病的一种非典型形式。
Stroke Vasc Neurol. 2024 Dec 30;9(6):660-670. doi: 10.1136/svn-2023-002992.
4
Surgical outcomes following encephaloduroarteriosynangiosis in moyamoya disease associated with hyperhomocysteinemia.镰状细胞贫血伴同高同型半胱氨酸血症患者行颅内外血管搭桥术后的手术效果。
Brain Behav. 2023 Aug;13(8):e3093. doi: 10.1002/brb3.3093. Epub 2023 Jun 29.
5
To explore the effectiveness of atorvastatin in the postoperative formation of collateral blood vessels after encephaloduroarteriosynangiosis in patients with moyamoya disease: a prospective double-blind randomized controlled study.探讨阿托伐他汀对烟雾病患者脑-硬脑膜-动脉血管融通术后侧支血管形成的有效性:一项前瞻性双盲随机对照研究。
Front Neurol. 2023 Jun 1;14:1169253. doi: 10.3389/fneur.2023.1169253. eCollection 2023.
6
Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases.烟雾病及相关血管疾病中血管生成与炎症的分子和细胞生物学的生理及病理生理机制
Front Neurol. 2023 May 16;14:661611. doi: 10.3389/fneur.2023.661611. eCollection 2023.
7
Chinese expert consensus on the treatment of MMD.烟雾病治疗的中国专家共识
Chin Neurosurg J. 2023 Feb 23;9(1):5. doi: 10.1186/s41016-023-00318-3.
8
A single - center retrospective observational study on patients undergoing Encephalo-Duro-Arterio -Myo-Synangiosis in patients with moyamoya disease.一项针对烟雾病患者行脑-硬脑膜-动脉-肌肉-联合血管搭桥术的单中心回顾性观察研究。
Brain Circ. 2022 Jun 30;8(2):94-101. doi: 10.4103/bc.bc_20_22. eCollection 2022 Apr-Jun.
9
Recognition of the Effect of Indirect Revascularization for Moyamoya Disease: The Balance Between the Stage Progression and Neoangiogenesis.认识间接血运重建术对烟雾病的疗效:疾病进展与新生血管形成之间的平衡
Front Neurol. 2022 May 6;13:861187. doi: 10.3389/fneur.2022.861187. eCollection 2022.
10
The Potential Mechanism Behind Native and Therapeutic Collaterals in Moyamoya.烟雾病中天然侧支循环和治疗性侧支循环背后的潜在机制
Front Neurol. 2022 Apr 26;13:861184. doi: 10.3389/fneur.2022.861184. eCollection 2022.